Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-28 4:30 pm Purchase | 2022-07-25 | 13D | Avenue Therapeutics, Inc. ATXI | InvaGen Pharmaceuticals Inc. | 9,476 46.950% | 533 (+5.96%) | Filing History |
| 2022-02-14 08:31 am Purchase | 2021-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | Nantahala Capital Management, LLC | 1,292 7.700% | 1,292 (New Position) | Filing History |
| 2022-02-09 3:24 pm Sale | 2021-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | The Vanguard Group | 402 2.420% | -433 (-51.83%) | Filing History |
| 2022-02-09 3:24 pm Sale | 2021-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | VANGUARD INDEX FUNDS | 402 2.420% | -343 (-46.04%) | Filing History |
| 2021-02-12 5:20 pm Sale | 2020-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | Opaleye Management Inc. | 0 0.000% | -920 (Position Closed) | Filing History |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | The Vanguard Group | 835 5.610% | 835 (New Position) | Filing History |
| 2021-02-08 10:37 am Purchase | 2020-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | VANGUARD INDEX FUNDS | 746 5.010% | 746 (New Position) | Filing History |